Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine – data from the REFINE study
Open Access
- 4 June 2026
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 46 (6)
Abstract
Background: Individuals with difficult-to-treat migraine, including resistant migraine (ResM) and refractory migraine (RefM), might experience treatment delays, undergo unnecessary diagnostic tests and receive misdiagnoses, which might influence treatment outcomes. For this reason, we hypothesized that individuals with ResM and RefM might report more diagnostic tests and misdiagnoses in their medical history compared with those with non-resistant/non-refractory migraine (NRNRM). Methods: This analysis used baseline, cross-sectional data from the REFINE study, a multicenter, prospective observational study conducted in 15 European tertiary headache centers. Adults with episodic or chronic migraine were classified into RefM, ResM, or NRNRM groups. Baseline data were analyzed to assess the frequency of previous diagnostic tests and misdiagnoses. Results: Overall, 689 participants were included with a median age of 46 years (interquartile range 36–53); 570 participants (82.7%) were female; 355 (51.5%) had NRNRM, 261 (37.9%) ResM, and 73 (10.9%) RefM. Referring to diagnostic tests, 335 participants (48.7%) had one and 237 (34.4%) multiple brain magnetic resonance imaging scans. ResM and RefM participants underwent more diagnostic tests than NRNRM. Overall, 193 participants (28.0%) had at least one prior headache misdiagnosis, most commonly cervical spine disorders and sinusitis; misdiagnoses were more frequent in NRNRM and ResM than in RefM (31.1%, 28.5%, and 15.1%, respectively; p = 0.025). Misdiagnosis rates were not influenced by age, sex, disease duration, or comorbidities. Conclusions: Diagnostic tests use and misdiagnoses are highly prevalent in all the three groups of individuals with ResM, RefM, and NRNRM with some differences across the three groups that may depend on multiple factors. Our findings emphasize a need for better diagnostic accuracy and care pathway across the entire spectrum of migraine, to avoid unnecessary diagnostic tests and misdiagnoses.Keywords
Funding Information
- Ministero della Salute (Ricerca Finalizzata 2021 (project code: GR-2021-12)
This publication has 18 references indexed in Scilit:
- Healthcare resource use and costs associated with the misdiagnosis of migraineHeadache: The Journal of Head and Face Pain, 2024
- Predictive performance of the common red flags in emergency department headache patients: a HEAD and HEAD-Colombia studyEmergency Medicine Journal, 2024
- Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet Neurology, 2024
- Resistant and refractory migraine: clinical presentation, pathophysiology, and managementEBioMedicine, 2023
- Risk factors for migraine disease progression: a narrative review for a patient-centered approachJournal of Neurology, 2023
- Headache EmergenciesNeurologic Clinics, 2021
- Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes StudyHeadache: The Journal of Head and Face Pain, 2021
- Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohortEuropean Journal of Neurology, 2019
- Migraine Progression: A Systematic ReviewHeadache: The Journal of Head and Face Pain, 2018
- Prevalence of Migraine in Patients With a History of Self-reported or Physician-Diagnosed "Sinus" HeadacheArchives of internal medicine (1960), 2004